PDB Short entry for 5L6P HEADER TRANSFERASE 30-MAY-16 5L6P TITLE EPHB3 KINASE DOMAIN COVALENTLY BOUND TO AN IRREVERSIBLE INHIBITOR TITLE 2 (COMPOUND 6) COMPND MOL_ID: 1; COMPND 2 MOLECULE: EPHRIN TYPE-B RECEPTOR 3; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: EPH-LIKE TYROSINE KINASE 2,EPH-LIKE KINASE 2,EMBRYONIC COMPND 5 KINASE 2,HEK2,TYROSINE-PROTEIN KINASE TYRO6; COMPND 6 EC: 2.7.10.1; COMPND 7 ENGINEERED: YES; COMPND 8 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: EPHB3, ETK2, HEK2, TYRO6; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS KINASE, IRREVERSIBLE INHIBITOR, QUINAZOLINE, SIGNALING, TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR M.SCHIMPL,R.OVERMAN,A.KUNG,Y.-C.CHEN,F.NI,J.ZHU,M.TURNER,H.MOLINA, AUTHOR 2 C.ZHANG REVDAT 3 10-JAN-24 5L6P 1 REMARK REVDAT 2 07-SEP-16 5L6P 1 JRNL REVDAT 1 10-AUG-16 5L6P 0 JRNL AUTH A.KUNG,Y.C.CHEN,M.SCHIMPL,F.NI,J.ZHU,M.TURNER,H.MOLINA, JRNL AUTH 2 R.OVERMAN,C.ZHANG JRNL TITL DEVELOPMENT OF SPECIFIC, IRREVERSIBLE INHIBITORS FOR A JRNL TITL 2 RECEPTOR TYROSINE KINASE EPHB3. JRNL REF J.AM.CHEM.SOC. V. 138 10554 2016 JRNL REFN ESSN 1520-5126 JRNL PMID 27478969 JRNL DOI 10.1021/JACS.6B05483 REMARK 2 REMARK 2 RESOLUTION. 2.26 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER 2.11.6 REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SHARFF,SMART,VONRHEIN, REMARK 3 : WOMACK,MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.26 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 37.87 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 95.7 REMARK 3 NUMBER OF REFLECTIONS : 15939 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.206 REMARK 3 R VALUE (WORKING SET) : 0.205 REMARK 3 FREE R VALUE : 0.232 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.860 REMARK 3 FREE R VALUE TEST SET COUNT : 774 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.000 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 8 REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 2.26 REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 2.42 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 78.52 REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : 2299 REMARK 3 BIN R VALUE (WORKING + TEST SET) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 2194 REMARK 3 BIN R VALUE (WORKING SET) : 0.2100 REMARK 3 BIN FREE R VALUE : 0.2750 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 4.57 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 105 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2122 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 27 REMARK 3 SOLVENT ATOMS : 77 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 38.99 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 55.84 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 8.98090 REMARK 3 B22 (A**2) : 8.26020 REMARK 3 B33 (A**2) : -17.24110 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.320 REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : 0.275 REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : 0.200 REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : 0.266 REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : 0.198 REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.893 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.884 REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : 2223 ; 2.000 ; HARMONIC REMARK 3 BOND ANGLES : 3036 ; 2.000 ; HARMONIC REMARK 3 TORSION ANGLES : 757 ; 2.000 ; SINUSOIDAL REMARK 3 TRIGONAL CARBON PLANES : 51 ; 2.000 ; HARMONIC REMARK 3 GENERAL PLANES : 322 ; 5.000 ; HARMONIC REMARK 3 ISOTROPIC THERMAL FACTORS : 2223 ; 20.000 ; HARMONIC REMARK 3 BAD NON-BONDED CONTACTS : NULL ; NULL ; NULL REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : 286 ; 5.000 ; SEMIHARMONIC REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : 2535 ; 4.000 ; SEMIHARMONIC REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.010 REMARK 3 BOND ANGLES (DEGREES) : 1.03 REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 2.64 REMARK 3 OTHER TORSION ANGLES (DEGREES) : 16.69 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 1 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 SELECTION: { A|* } REMARK 3 ORIGIN FOR THE GROUP (A): 12.4196 -7.2007 -19.3001 REMARK 3 T TENSOR REMARK 3 T11: -0.1251 T22: -0.1988 REMARK 3 T33: -0.0698 T12: 0.0457 REMARK 3 T13: -0.0855 T23: -0.0588 REMARK 3 L TENSOR REMARK 3 L11: 2.3870 L22: 3.2786 REMARK 3 L33: 0.6879 L12: -1.0621 REMARK 3 L13: -0.1805 L23: 0.1626 REMARK 3 S TENSOR REMARK 3 S11: -0.2322 S12: -0.4626 S13: 0.2022 REMARK 3 S21: 0.6909 S22: 0.2330 S23: -0.2457 REMARK 3 S31: 0.0402 S32: 0.0921 S33: -0.0008 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 5L6P COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 31-MAY-16. REMARK 100 THE DEPOSITION ID IS D_1200000217. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 23-JAN-16 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 8.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : DIAMOND REMARK 200 BEAMLINE : I02 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.97949 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : AIMLESS 0.5.17 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 15994 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.260 REMARK 200 RESOLUTION RANGE LOW (A) : 37.870 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 95.6 REMARK 200 DATA REDUNDANCY : 5.900 REMARK 200 R MERGE (I) : 0.09000 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 13.2000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.26 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.38 REMARK 200 COMPLETENESS FOR SHELL (%) : 75.7 REMARK 200 DATA REDUNDANCY IN SHELL : 4.00 REMARK 200 R MERGE FOR SHELL (I) : 0.34000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: MOLREP REMARK 200 STARTING MODEL: 3ZFY REMARK 200 REMARK 200 REMARK: PLATE REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 51.28 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.52 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 1,4-DIOXANE, TRIS BUFFER, MAGNESIUM REMARK 280 CHLORIDE, PH 8.5, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 23.62000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 63.37500 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 28.47500 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 63.37500 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 23.62000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 28.47500 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 280 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 13410 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: 6.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 613 REMARK 465 SER A 614 REMARK 465 SER A 615 REMARK 465 ASP A 616 REMARK 465 PRO A 617 REMARK 465 ASN A 618 REMARK 465 GLU A 619 REMARK 465 ALA A 620 REMARK 465 VAL A 621 REMARK 465 ARG A 622 REMARK 465 GLU A 623 REMARK 465 PHE A 624 REMARK 465 ALA A 625 REMARK 465 LYS A 626 REMARK 465 GLU A 627 REMARK 465 ILE A 628 REMARK 465 ASP A 629 REMARK 465 VAL A 630 REMARK 465 SER A 631 REMARK 465 ALA A 906 REMARK 465 SER A 907 REMARK 465 ALA A 908 REMARK 465 GLN A 909 REMARK 465 SER A 910 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LYS A 634 CG CD CE NZ REMARK 470 GLU A 637 CG CD OE1 OE2 REMARK 470 ARG A 651 CG CD NE CZ NH1 NH2 REMARK 470 LYS A 653 CG CD CE NZ REMARK 470 GLN A 654 CG CD OE1 NE2 REMARK 470 ARG A 657 CG CD NE CZ NH1 NH2 REMARK 470 LYS A 668 CG CD CE NZ REMARK 470 GLU A 673 CG CD OE1 OE2 REMARK 470 ARG A 674 CG CD NE CZ NH1 NH2 REMARK 470 LYS A 703 CG CD CE NZ REMARK 470 ARG A 705 CG CD NE CZ NH1 NH2 REMARK 470 ARG A 781 CG CD NE CZ NH1 NH2 REMARK 470 LEU A 796 CG CD1 CD2 REMARK 470 LYS A 799 CG CD CE NZ REMARK 470 ARG A 813 NE CZ NH1 NH2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 CYS A 717 -152.38 56.70 REMARK 500 ARG A 757 -5.20 77.70 REMARK 500 ASP A 758 44.00 -148.38 REMARK 500 TRP A 840 -124.20 52.27 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 6P8 A 1001 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue DIO A 1002 DBREF 5L6P A 616 910 UNP P54753 EPHB3_HUMAN 616 910 SEQADV 5L6P GLY A 613 UNP P54753 EXPRESSION TAG SEQADV 5L6P SER A 614 UNP P54753 EXPRESSION TAG SEQADV 5L6P SER A 615 UNP P54753 EXPRESSION TAG SEQADV 5L6P PRO A 899 UNP P54753 ALA 899 ENGINEERED MUTATION SEQRES 1 A 298 GLY SER SER ASP PRO ASN GLU ALA VAL ARG GLU PHE ALA SEQRES 2 A 298 LYS GLU ILE ASP VAL SER CYS VAL LYS ILE GLU GLU VAL SEQRES 3 A 298 ILE GLY ALA GLY GLU PHE GLY GLU VAL CYS ARG GLY ARG SEQRES 4 A 298 LEU LYS GLN PRO GLY ARG ARG GLU VAL PHE VAL ALA ILE SEQRES 5 A 298 LYS THR LEU LYS VAL GLY TYR THR GLU ARG GLN ARG ARG SEQRES 6 A 298 ASP PHE LEU SER GLU ALA SER ILE MET GLY GLN PHE ASP SEQRES 7 A 298 HIS PRO ASN ILE ILE ARG LEU GLU GLY VAL VAL THR LYS SEQRES 8 A 298 SER ARG PRO VAL MET ILE LEU THR GLU PHE MET GLU ASN SEQRES 9 A 298 CYS ALA LEU ASP SER PHE LEU ARG LEU ASN ASP GLY GLN SEQRES 10 A 298 PHE THR VAL ILE GLN LEU VAL GLY MET LEU ARG GLY ILE SEQRES 11 A 298 ALA ALA GLY MET LYS TYR LEU SER GLU MET ASN TYR VAL SEQRES 12 A 298 HIS ARG ASP LEU ALA ALA ARG ASN ILE LEU VAL ASN SER SEQRES 13 A 298 ASN LEU VAL CYS LYS VAL SER ASP PHE GLY LEU SER ARG SEQRES 14 A 298 PHE LEU GLU ASP ASP PRO SER ASP PRO THR TYR THR SER SEQRES 15 A 298 SER LEU GLY GLY LYS ILE PRO ILE ARG TRP THR ALA PRO SEQRES 16 A 298 GLU ALA ILE ALA TYR ARG LYS PHE THR SER ALA SER ASP SEQRES 17 A 298 VAL TRP SER TYR GLY ILE VAL MET TRP GLU VAL MET SER SEQRES 18 A 298 TYR GLY GLU ARG PRO TYR TRP ASP MET SER ASN GLN ASP SEQRES 19 A 298 VAL ILE ASN ALA VAL GLU GLN ASP TYR ARG LEU PRO PRO SEQRES 20 A 298 PRO MET ASP CYS PRO THR ALA LEU HIS GLN LEU MET LEU SEQRES 21 A 298 ASP CYS TRP VAL ARG ASP ARG ASN LEU ARG PRO LYS PHE SEQRES 22 A 298 SER GLN ILE VAL ASN THR LEU ASP LYS LEU ILE ARG ASN SEQRES 23 A 298 PRO ALA SER LEU LYS VAL ILE ALA SER ALA GLN SER HET 6P8 A1001 21 HET DIO A1002 6 HETNAM 6P8 ~{N}-(4-PHENYLAZANYLQUINAZOLIN-7-YL)ETHANAMIDE HETNAM DIO 1,4-DIETHYLENE DIOXIDE FORMUL 2 6P8 C16 H14 N4 O FORMUL 3 DIO C4 H8 O2 FORMUL 4 HOH *77(H2 O) HELIX 1 AA1 THR A 672 GLY A 687 1 16 HELIX 2 AA2 ALA A 718 ASN A 726 1 9 HELIX 3 AA3 THR A 731 MET A 752 1 22 HELIX 4 AA4 ALA A 760 ARG A 762 5 3 HELIX 5 AA5 PRO A 801 THR A 805 5 5 HELIX 6 AA6 ALA A 806 ARG A 813 1 8 HELIX 7 AA7 THR A 816 SER A 833 1 18 HELIX 8 AA8 SER A 843 GLN A 853 1 11 HELIX 9 AA9 PRO A 864 TRP A 875 1 12 HELIX 10 AB1 LYS A 884 ASN A 898 1 15 HELIX 11 AB2 PRO A 899 VAL A 904 5 6 SHEET 1 AA1 5 VAL A 633 ALA A 641 0 SHEET 2 AA1 5 GLY A 645 LEU A 652 -1 O ARG A 649 N GLU A 637 SHEET 3 AA1 5 VAL A 660 LEU A 667 -1 O ILE A 664 N CYS A 648 SHEET 4 AA1 5 MET A 708 GLU A 712 -1 O THR A 711 N ALA A 663 SHEET 5 AA1 5 LEU A 697 VAL A 701 -1 N GLY A 699 O LEU A 710 SHEET 1 AA2 2 ILE A 764 VAL A 766 0 SHEET 2 AA2 2 CYS A 772 VAL A 774 -1 O LYS A 773 N LEU A 765 LINK SG CYS A 717 C15 6P8 A1001 1555 1555 1.82 CISPEP 1 ARG A 705 PRO A 706 0 3.58 SITE 1 AC1 9 ALA A 663 LYS A 665 THR A 711 GLU A 712 SITE 2 AC1 9 MET A 714 CYS A 717 LEU A 765 SER A 775 SITE 3 AC1 9 ASP A 776 SITE 1 AC2 6 MET A 686 PHE A 689 TYR A 754 HIS A 756 SITE 2 AC2 6 VAL A 774 PHE A 777 CRYST1 47.240 56.950 126.750 90.00 90.00 90.00 P 21 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.021169 0.000000 0.000000 0.00000 SCALE2 0.000000 0.017559 0.000000 0.00000 SCALE3 0.000000 0.000000 0.007890 0.00000